Settlement Reached With Eli Lilly in DES Breast Cancer Trial

For decades, a small group of plaintiffs lawyers have been pressing claims against companies that made and sold a synthetic estrogen known as diethylstilbestrol, or DES, which was prescribed to millions of pregnant women to ward off premature births and miscarriages from 1948 to 1971.

This article requires premium access

This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.